NASDAQ:REGN

Regeneron Pharmaceuticals News Headlines

$653.54
+1.54 (+0.24 %)
(As of 09/16/2021 02:29 PM ET)
Add
Compare
Today's Range
$643.31
$653.90
50-Day Range
$574.03
$680.96
52-Week Range
$441.00
$686.62
Volume10,313 shs
Average Volume873,390 shs
Market Capitalization$69.90 billion
P/E Ratio11.74
Dividend YieldN/A
Beta0.16

Media Mentions By Week

Regeneron Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

REGN
News Sentiment

0.56

0.30

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

REGN Articles
This Week

18

11

REGN Articles
Average Week

Get Regeneron Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter.

Regeneron Pharmaceuticals (NASDAQ REGN) News Headlines Today

SourceHeadline
Regeneron Pharmaceuticals (NASDAQ:REGN) Coverage Initiated by Analysts at UBS GroupRegeneron Pharmaceuticals (NASDAQ:REGN) Coverage Initiated by Analysts at UBS Group
marketbeat.com - September 9 at 8:41 AM
Interesting REGN Put And Call Options For January 2024Interesting REGN Put And Call Options For January 2024
nasdaq.com - September 16 at 8:55 AM
U.S. to pay $2.9 billion for an additional 1.4 million doses of Regenerons COVID-19 therapyU.S. to pay $2.9 billion for an additional 1.4 million doses of Regeneron's COVID-19 therapy
finance.yahoo.com - September 15 at 9:49 AM
Dow Jones Today, Stocks Open Flat With Empire State Data, Goldman/GreenSky Deal, ThoughtWorks IPO And Microsoft Dividend In FocusDow Jones Today, Stocks Open Flat With Empire State Data, Goldman/GreenSky Deal, ThoughtWorks IPO And Microsoft Dividend In Focus
finance.yahoo.com - September 15 at 9:49 AM
Regeneron Pharmaceuticals (NASDAQ:REGN) Receives "Buy" Rating from HC WainwrightRegeneron Pharmaceuticals (NASDAQ:REGN) Receives "Buy" Rating from HC Wainwright
americanbankingnews.com - September 15 at 9:18 AM
Regeneron To Supply Additional 1.4 Mln Doses Of COVID-19 Therapy To U.S.Regeneron To Supply Additional 1.4 Mln Doses Of COVID-19 Therapy To U.S.
markets.businessinsider.com - September 14 at 11:46 PM
U.S. to buy 1.4 mln additional doses of Regenerons COVID-19 therapyU.S. to buy 1.4 mln additional doses of Regeneron's COVID-19 therapy
msn.com - September 14 at 6:29 PM
UPDATE 1-U.S. to buy 1.4 mln additional doses of Regenerons COVID-19 therapyUPDATE 1-U.S. to buy 1.4 mln additional doses of Regeneron's COVID-19 therapy
finance.yahoo.com - September 14 at 6:29 PM
aTyr (LIFE) Surges on Positive Data on Lead Candidate ATYR1923aTyr (LIFE) Surges on Positive Data on Lead Candidate ATYR1923
finance.yahoo.com - September 14 at 1:29 PM
Regeneron Pharmaceuticals Inc. stock outperforms market on strong trading dayRegeneron Pharmaceuticals Inc. stock outperforms market on strong trading day
marketwatch.com - September 11 at 3:59 AM
Regeneron Pharmaceuticals (NASDAQ:REGN) Now Covered by UBS GroupRegeneron Pharmaceuticals (NASDAQ:REGN) Now Covered by UBS Group
americanbankingnews.com - September 9 at 9:02 AM
‘If you don’t get vaccinated, you will get Covid at this point’: Doctor‘If you don’t get vaccinated, you will get Covid at this point’: Doctor
finance.yahoo.com - September 8 at 3:17 PM
Analyst Ratings For Regeneron PharmaceuticalsAnalyst Ratings For Regeneron Pharmaceuticals
markets.businessinsider.com - September 7 at 2:14 PM
5 Stocks With High ROE as Markets Stumble on Tepid Jobs Report5 Stocks With High ROE as Markets Stumble on Tepid Jobs Report
finance.yahoo.com - September 7 at 2:14 PM
3 Hot Stocks to Buy in September3 Hot Stocks to Buy in September
finance.yahoo.com - September 7 at 2:14 PM
Bet on These 5 Low-Beta Stocks to Combat Market VolatilityBet on These 5 Low-Beta Stocks to Combat Market Volatility
finance.yahoo.com - September 7 at 2:14 PM
Will Regenerons (REGN) Antibody Cocktail Fuel Further Growth?Will Regeneron's (REGN) Antibody Cocktail Fuel Further Growth?
finance.yahoo.com - September 7 at 2:14 PM
Morgan Stanley Boosts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $606.00Morgan Stanley Boosts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $606.00
americanbankingnews.com - September 7 at 1:56 PM
Now May Be the Big Moment for These 2 COVID StocksNow May Be the Big Moment for These 2 COVID Stocks
finance.yahoo.com - September 2 at 6:17 AM
Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & MoreBiotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More
msn.com - September 1 at 3:15 PM
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 1-Year High at $686.56Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 1-Year High at $686.56
americanbankingnews.com - September 1 at 2:44 PM
Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 1-Year High at $686.56Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 1-Year High at $686.56
americanbankingnews.com - September 1 at 2:44 PM
Regeneron Is More Than a Covid Play. This Drug Could Be the World’s Biggest Selling by 2030.Regeneron Is More Than a Covid Play. This Drug Could Be the World’s Biggest Selling by 2030.
finance.yahoo.com - August 31 at 2:09 PM
Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic DermatitisDupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
finance.yahoo.com - August 30 at 10:41 AM
Bronte Capital on Regeneron (REGN): “A Winner in Mouse Genetics”Bronte Capital on Regeneron (REGN): “A Winner in Mouse Genetics”
finance.yahoo.com - August 27 at 6:23 PM
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week High at $674.13Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week High at $674.13
americanbankingnews.com - August 26 at 11:04 AM
Regenerons (REGN) Wet AMD Study on High Dose Eylea Meets GoalRegeneron's (REGN) Wet AMD Study on High Dose Eylea Meets Goal
nasdaq.com - August 25 at 6:15 PM
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular DegenerationRegeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
finance.yahoo.com - August 25 at 2:19 AM
Regeneron Announces Encouraging Topline Phase 2 Data of High-dose aflibercept in Wet Age-related Macular DegenerationRegeneron Announces Encouraging Topline Phase 2 Data of High-dose aflibercept in Wet Age-related Macular Degeneration
finance.yahoo.com - August 24 at 8:55 AM
Regeneron Pharmaceuticals Reaches Analyst Target PriceRegeneron Pharmaceuticals Reaches Analyst Target Price
nasdaq.com - August 23 at 5:54 PM
Return on Capital Employed Insights for Regeneron PharmaceuticalsReturn on Capital Employed Insights for Regeneron Pharmaceuticals
benzinga.com - August 23 at 5:54 PM
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Increased to $727.00 by Analysts at BenchmarkRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Increased to $727.00 by Analysts at Benchmark
americanbankingnews.com - August 23 at 9:56 AM
Regeneron Pharmaceuticals (NASDAQ:REGN) Earns "Buy" Rating from HC WainwrightRegeneron Pharmaceuticals (NASDAQ:REGN) Earns "Buy" Rating from HC Wainwright
americanbankingnews.com - August 22 at 1:22 PM
U.K. Authorizes Regenerons Antibody Cocktail To Prevent & Treat Acute COVID-19 InfectionU.K. Authorizes Regeneron's Antibody Cocktail To Prevent & Treat Acute COVID-19 Infection
nasdaq.com - August 20 at 4:50 PM
U.K. approves antibody treatment cocktail for COVID-19U.K. approves antibody treatment cocktail for COVID-19
finance.yahoo.com - August 20 at 8:28 AM
UK Authorizes Regeneron Antibody Cocktail to Prevent and Treat Acute COVID-19 InfectionUK Authorizes Regeneron Antibody Cocktail to Prevent and Treat Acute COVID-19 Infection
finance.yahoo.com - August 20 at 8:28 AM
UPDATE 1-UK approves Regeneron/Roche antibody cocktail for COVID-19UPDATE 1-UK approves Regeneron/Roche antibody cocktail for COVID-19
finance.yahoo.com - August 20 at 3:28 AM
Regeneron (REGN) Antibody Cocktail for COVID-19 Gets a BoostRegeneron (REGN) Antibody Cocktail for COVID-19 Gets a Boost
nasdaq.com - August 19 at 10:28 PM
Why Regeneron Pharmaceuticals (REGN) Isnt Done Growing Earnings YetWhy Regeneron Pharmaceuticals (REGN) Isn't Done Growing Earnings Yet
nasdaq.com - August 19 at 5:28 PM
An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests Its 27% UndervaluedAn Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 27% Undervalued
au.finance.yahoo.com - August 18 at 4:57 PM
Updating Our Bullish Strategy for Regeneron PharmaceuticalsUpdating Our Bullish Strategy for Regeneron Pharmaceuticals
realmoney.thestreet.com - August 18 at 4:57 PM
Regeneron Stock Jumps as GOP Governors Boost Its Antibody TherapyRegeneron Stock Jumps as GOP Governors Boost Its Antibody Therapy
barrons.com - August 18 at 4:57 PM
Jim Cramer: The Fortunes Have Been Restored for Regeneron and AbbottJim Cramer: The Fortunes Have Been Restored for Regeneron and Abbott
finance.yahoo.com - August 17 at 10:16 PM
Top donor of Florida’s Ron DeSantis invests in COVID drug that governor promotesTop donor of Florida’s Ron DeSantis invests in COVID drug that governor promotes
finance.yahoo.com - August 17 at 10:16 PM
How investors could pose as a headwind for ModernaHow investors could pose as a headwind for Moderna
finance.yahoo.com - August 16 at 4:52 PM
Regenerons Antibody Cocktail Authorized for Preventing COVID: Why Its Not a Big Deal for the StockRegeneron's Antibody Cocktail Authorized for Preventing COVID: Why It's Not a Big Deal for the Stock
finance.yahoo.com - August 14 at 4:57 PM
Notable Friday Option Activity: REGN, AAL, MCDNotable Friday Option Activity: REGN, AAL, MCD
nasdaq.com - August 13 at 10:19 PM
Nasdaq 100 Movers: BIDU, REGNNasdaq 100 Movers: BIDU, REGN
nasdaq.com - August 13 at 4:56 PM
Dont Ignore The Fact That This Insider Just Sold Some Shares In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Don't Ignore The Fact That This Insider Just Sold Some Shares In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
nasdaq.com - August 11 at 7:39 AM
Regeneron Pharmaceuticals Inc (REGN) EVP & General Mgr, Industrial Plew Daniel P Van Sold ...Regeneron Pharmaceuticals Inc (REGN) EVP & General Mgr, Industrial Plew Daniel P Van Sold ...
finance.yahoo.com - August 10 at 10:47 PM
Regeneron sees uptick in COVID-19 therapy use as cases riseRegeneron sees uptick in COVID-19 therapy use as cases rise
reuters.com - August 6 at 5:40 PM
Get Regeneron Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.